Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
PaperCitations, authors & open-access status
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 725 citations, 2013 year and closed oa status.
725
Citations
2013
Year
closed
OA Status